[1] 赵军.银杏叶片联合环磷腺苷治疗冠心病慢性心力衰竭临床疗效[J].中医药学报,2015,6(5):107~109. [2] 赵明明,张鹏.BNP在心力衰竭应用中的研究进展[J].西南国防医药,2015,25(7):805~807. [3] 许静莉,张继军.冠心病心力衰竭患者血BNP、MMP-2的变化及临床意义[J].陕西医学杂志,2014,11(12):1652~1653. [4] 中华医学会心血管病学分会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076. [5] Sekikawa A, Doyle M F, Kuller L H. Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan.[J]. Trends Cardiovasc Med, 2015, 25(8):717~723. [6] Wong M C, Tam W W, Lao X Q, et al. The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: a cohort study.[J]. Int Cardiol, 2014, 175(3):425~432. [7] Nam S, Yoon Y, Choi D, et al. Degradation characteristics of metoprolol during UV/chlorination reaction and a factorial design optimization.[J].Hazard Mater, 2015, 285:453~463. [8] 郑定逸.银杏叶提取物治疗老年冠心病心力衰竭疗效观察[J].中国乡村医药,2014,10(1):31~32. [9] 潘洪平,危华玲,陈英,等.复方银杏叶片的急性毒性实验研究[J].时珍国医国药,2007,18(6):1325. [10] 丁晓云,罗正义.银杏叶片联合美托洛尔治疗冠心病心力衰竭的临床研究[J].现代药物与临床,2016,31(12):1917~1920. [11] 原永明,王慧,尹良平,等.慢性心力衰竭患者BNP、hs-CRP水平检测的临床意义[J].检验医学,2015,30(6):591~592.
2018, Vol. 24 
冀公网安备13080202000677号